CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation.
CP: Molecular biology
CP:Cancer
CPSF6
alternative polyadenylation
cancer cell proliferation
phase separation
phosphorylation
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
31 10 2023
31 10 2023
Historique:
received:
15
09
2022
revised:
20
06
2023
accepted:
18
09
2023
medline:
6
11
2023
pubmed:
1
10
2023
entrez:
1
10
2023
Statut:
ppublish
Résumé
Cancer cells usually exhibit shortened 3' untranslated regions (UTRs) due to alternative polyadenylation (APA) to promote cell proliferation and migration. Upregulated CPSF6 leads to a systematic prolongation of 3' UTRs, but CPSF6 expression in tumors is typically higher than that in healthy tissues. This contradictory observation suggests that it is necessary to investigate the underlying mechanism by which CPSF6 regulates APA switching in cancer. Here, we find that CPSF6 can undergo liquid-liquid phase separation (LLPS), and elevated LLPS is associated with the preferential usage of the distal poly(A) sites. CLK2, a kinase upregulated in cancer cells, destructs CPSF6 LLPS by phosphorylating its arginine/serine-like domain. The reduction of CPSF6 LLPS can lead to a shortened 3' UTR of cell-cycle-related genes and accelerate cell proliferation. These results suggest that CPSF6 LLPS, rather than its expression level, may be responsible for APA regulation in cancer cells.
Identifiants
pubmed: 37777964
pii: S2211-1247(23)01209-3
doi: 10.1016/j.celrep.2023.113197
pii:
doi:
Substances chimiques
3' Untranslated Regions
0
mRNA Cleavage and Polyadenylation Factors
0
cleavage factor Im, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
113197Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.